ADMINISTRATIVE PROCEEDING
File No. 3-20073

September 25, 2020 - The Securities and Exchange Commission today announced settled charges against Aeon Global Health Corp., a Georgia-based healthcare company, for failing to maintain internal control over financial reporting (ICFR).

The SEC's order found that Aeon failed to maintain, and did not remediate material weaknesses in, ICFR for fourteen consecutive reporting periods ending March 31, 2016 through June 30, 2019. According to the SEC's order, during that same period Aeon filed three restatements to correct material errors in its financial statements for multiple periods.

The SEC's order finds that Aeon violated the reporting, books and records, and internal controls provisions of Sections 13(a), 13(b)(2)(A) and 13(b)(2)(B) of the Securities Exchange Act of 1934 and Rules 13a-13 and 13a-15(a) thereunder. Without admitting or denying the Commission's findings, Aeon consented to the entry of a cease-and-desist order and has undertaken to retain an independent consultant.

The SEC's investigation was conducted by Peter Altenbach, Tian Wen and Steven G. Rawlings of the New York Regional Office, and supervised by Lara Shalov Mehraban.